[Breast cancer after Hodgkin disease]

Gynecol Obstet Fertil. 2012 Jan;40(1):55-7. doi: 10.1016/j.gyobfe.2011.10.012. Epub 2011 Dec 20.
[Article in French]

Abstract

Secondary breast cancer represents 6 to 9% of secondary neoplasia after treatments for Hodgkin Disease (HD). Mostly, they appear 10 years after the end of treatments for HD. The most important risk factors are mantle field irradiation and the young age. The means of screening and treatments are still in discussion. We report a case of bilateral intraductal and invasive carcinoma that occurred 16 years after treatments for HD, developing its particularities in diagnosis and treatment, particularly place of conservative treatments and sentinel lymph node biopsy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / surgery
  • Breast Neoplasms / therapy*
  • Carcinoma, Ductal, Breast / diagnosis
  • Carcinoma, Ductal, Breast / drug therapy
  • Carcinoma, Ductal, Breast / surgery
  • Carcinoma, Ductal, Breast / therapy*
  • Female
  • Hodgkin Disease* / drug therapy
  • Hodgkin Disease* / radiotherapy
  • Humans
  • Mastectomy
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / drug therapy
  • Neoplasms, Second Primary / surgery
  • Neoplasms, Second Primary / therapy*
  • Plastic Surgery Procedures
  • Postoperative Care
  • Risk Factors
  • Sentinel Lymph Node Biopsy
  • Tamoxifen / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen